For example, antibodies against DNA topoisomerase I or Th/To ribonucleoprotein are predictors of the development of interstitial lung disease (ILD) while antibodies against centromeric proteins are mainly associated with calcinosis and pulmonary arterial hypertension, together with a low risk of ILD. This evidence concerns the gene TOP1 and calcinosis.